Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Quality, seriousness and credibility

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Nov 14, 2022 10:07am

210 Views

Post# 35096363

RE:Quality, seriousness and credibility

My opinion is there are far greater plusses with each patient update so no matter which path TLT takes towards commercialization the end result will mean recognition on all major news outlets. I think the only speculation after that will be percentage of NMIBC will Theralase get in their first year 10, 20, 30% unknown yet. Definitely we should see movement in NML, Brain & Lung soon after the 450 day results confirm durability from 270 & 360.

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3